Thiogenesis Therapeutics, Corp.
TTIPF
$0.44
$0.02897.03%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.01M | -3.31M | -3.48M | -3.75M | -2.55M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 204.60K | 245.10K | 287.10K | 356.40K | 425.60K |
| Change in Net Operating Assets | -204.80K | -67.90K | -45.20K | 980.60K | 20.80K |
| Cash from Operations | -3.01M | -3.13M | -3.24M | -2.41M | -2.10M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -2.39M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -2.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 25.00K |
| Issuance of Common Stock | 4.59M | 4.58M | 4.58M | 4.12M | 4.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 3.31M |
| Cash from Financing | 3.38M | 3.37M | 3.37M | 3.03M | 6.05M |
| Foreign Exchange rate Adjustments | 2.30K | -15.50K | -6.90K | 5.50K | -85.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 372.20K | 222.10K | 123.50K | 626.30K | 1.47M |